Recent trends in the incidence, treatment, and prognosis of patients with heart failure and atrial fibrillation (the worcester heart failure study)

American Journal of Cardiology

Volumn 111, Issue 10, 2013, Pages 1460-1465

  McManus, David D ^a   Saczynski, Jane S ^a   Lessard, Darleen ^a   Kinno, Menhel ^a   Pidikiti, Rahul ^a   Esa, Nada ^a   Harrington, Josephine ^a   Goldberg, Robert J ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CARDIOVASCULAR MORTALITY; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COMORBIDITY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART FAILURE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVASCULARIZATION; SURVIVAL; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

AGED; ATRIAL FIBRILLATION; CARDIOVASCULAR AGENTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; MALE; MASSACHUSETTS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84876984785     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.01.298     Document Type: Article

References (27)

1. D.M. Lloyd-Jones, M.G. Larson, E.P. Leip, A. Beiser, R.B. D'Agostino, W.B. Kannel, J.M. Murabito, R.S. Vasan, E.J. Benjamin, and D. Levy Lifetime risk for developing congestive heart failure: the Framingham Heart Study Circulation 106 2002 3068 3072
2. D.M. Lloyd-Jones, T.J. Wang, E.P. Leip, M.G. Larson, D. Levy, R.S. Vasan, R.B. D'Agostino, J.M. Massaro, A. Beiser, P.A. Wolf, and E.J. Benjamin Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 2004 1042 1046
3. J.S. Steinberg Atrial fibrillation: an emerging epidemic? Heart 90 2004 239 240
4. P.A. Wolf, R.D. Abbott, and W.B. Kannel Atrial fibrillation as an independent risk factor for stroke: the Framingham study Stroke 22 1991 983 988
5. E.J. Benjamin, P.A. Wolf, R.B. D'Agostino, H. Silbershatz, W.B. Kannel, and D. Levy Impact of atrial fibrillation on the risk of death: the Framingham Heart Study Circulation 98 1998 946 952
6. T.J. Wang, M.G. Larson, D. Levy, R.S. Vasan, E.P. Leip, P.A. Wolf, R.B. D'Agostino, J.M. Murabito, W.B. Kannel, and E.J. Benjamin Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study Circulation 107 2003 2920 2925
7. S.A. Lubitz, E.J. Benjamin, and P.T. Ellinor Atrial fibrillation in congestive heart failure Heart Fail Clin 6 2010 187 200
8. G.C. Fonarow, and E. Corday Overview of acutely decompensated congestive heart failure (ADHF): a report from the ADHERE registry Heart Fail Rev 9 2004 179 185
9. R.T. Greenlee, and H. Vidaillet Recent progress in the epidemiology of atrial fibrillation Curr Opin Cardiol 20 2005 7 14
10. R.J. Goldberg, C. Darling, B. Joseph, J. Saczynski, M. Chinali, D. Lessard, S. Pezzella, and F.A. Spencer Epidemiology of decompensated heart failure in a single community in the northeastern United States Am J Cardiol 104 2009 377 382
11. R.J. Goldberg, J. Ciampa, D. Lessard, T.E. Meyer, and F.A. Spencer Long-term survival after heart failure: a contemporary population-based perspective Arch Intern Med 167 2007 490 496
12. J.K. Ghali, R. Cooper, and E. Ford Trends in hospitalization rates for heart failure in the United States, 1973-1986: evidence for increasing population prevalence Arch Intern Med 150 1990 769 773
13. A.S. Go, E.M. Hylek, K.A. Phillips, Y. Chang, L.E. Henault, J.V. Selby, and D.E. Singer Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study JAMA 285 2001 2370 2375
14. P.E. Carson, G.R. Johnson, W.B. Dunkman, R.D. Fletcher, L. Farrell, and J.N. Cohn The influence of atrial fibrillation on prognosis in mild to moderate heart failure: the V-HEFT studies. The V-HEFT VA Cooperative Studies group Circulation 87 1993 VI102 VI110
15. A. Tveit, B. Flonaes, E. Aaser, K. Korneliussen, G. Froland, L. Gullestad, and M. Grundtvig No impact of atrial fibrillation on mortality risk in optimally treated heart failure patients Clin Cardiol 34 2011 537 542
16. M.D. Smit, M.L. Moes, A.H. Maass, I.D. Achekar, P.P. Van Geel, H.L. Hillege, D.J. van Veldhuisen, and I.C. Van Gelder The importance of whether atrial fibrillation or heart failure develops first Eur J Heart Fail 14 2012 1030 1040
17. D.L. Dries, D.V. Exner, B.J. Gersh, M.J. Domanski, M.A. Waclawiw, and L.W. Stevenson Atrial fibrillation is associated with an increased risk for mortality and heart failure progression in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a retrospective analysis of the SOLVD trials: studies of left ventricular dysfunction J Am Coll Cardiol 32 1998 695 703
18. Y. Miyasaka, M.E. Barnes, B.J. Gersh, S.S. Cha, K.R. Bailey, W. Abhayaratna, J.B. Seward, T. Iwasaka, and T.S. Tsang Incidence and mortality risk of congestive heart failure in atrial fibrillation patients: a community-based study over two decades Eur Heart J 27 2006 936 941
19. W.H. Maisel, and L.W. Stevenson Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy Am J Cardiol 91 2003 2D 8D
20. R.S. Vasan, E.J. Benjamin, and D. Levy Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective J Am Coll Cardiol 26 1995 1565 1574
21. J. Seiler, and W.G. Stevenson Atrial fibrillation in congestive heart failure Cardiol Rev 18 2010 38 50
22. S.E. Mountantonakis, M.V. Grau-Sepulveda, D.L. Bhatt, A.F. Hernandez, E.D. Peterson, and G.C. Fonarow Presence of atrial fibrillation is independently associated with adverse outcomes in patients hospitalized with heart failure: an analysis of Get With The Guidelines-heart failure Circ Heart Fail 5 2012 191 201
23. E. Anter, M. Jessup, and D.J. Callans Atrial fibrillation and heart failure: treatment considerations for a dual epidemic Circulation 119 2009 2516 2525
24. D.S. Lee, P. Gona, R.S. Vasan, M.G. Larson, E.J. Benjamin, T.J. Wang, J.V. Tu, and D. Levy Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the Framingham Heart Study of the National Heart, Lung, and Blood Institute Circulation 119 2009 3070 3077
25. L. Kober, K. Swedberg, J.J. McMurray, M.A. Pfeffer, E.J. Velazquez, R. Diaz, A.P. Maggioni, V. Mareev, G. Opolski, F. Van de Werf, F. Zannad, G. Ertl, S.D. Solomon, S. Zelenkofske, J.L. Rouleau, J.D. Leimberger, and R.M. Califf Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction Eur J Heart Fail 8 2006 591 598
26. C.W. Yancy, G.C. Fonarow, N.M. Albert, A.B. Curtis, W.G. Stough, M. Gheorghiade, J.T. Heywood, M.L. McBride, M.R. Mehra, C.M. O'Connor, D. Reynolds, and M.N. Walsh Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE-HF Am Heart J 157 2009 754 762.e2
27. G.C. Fonarow, N.M. Albert, A.B. Curtis, M. Gheorghiade, Y. Liu, M.R. Mehra, C.M. O'Connor, D. Reynolds, M.N. Walsh, and C.W. Yancy Incremental reduction in risk of death associated with use of guideline-recommended therapies in patients with heart failure: a nested case-control analysis of improve HF J Am Heart Assoc 1 2012 16 26